A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections (2021)
- Authors:
- USP affiliated authors: DURIGON, EDISON LUIZ - ICB ; MACHADO, RAFAEL RAHAL GUARAGNA - ICB ; SOARES, CAMILA PEREIRA - ICB
- Unidade: ICB
- DOI: 10.1111/trf.16323
- Subjects: MICROBIOLOGIA; SANGUE; PLASMA; COVID-19; ESTUDOS LONGITUDINAIS; CINÉTICA QUÍMICA; ANTICORPOS; REAÇÃO EM CADEIA POR POLIMERASE; ESTUDOS DE COORTES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: Wiley-Blackwell Publishing, Inc.
- Publisher place: Hoboken
- Date published: 2021
- Source:
- Título: Transfusion
- ISSN: 1537-2995
- Volume/Número/Paginação/Ano: 14 p., 2021
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
WENDEL, Silvano et al. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections. Transfusion, p. 14 , 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16323. Acesso em: 31 mar. 2026. -
APA
Wendel, S., Wendel, R. F., Fachini, R., Candelaria, G., Scuracchio, P., Achkar, R., et al. (2021). A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections. Transfusion, 14 . doi:10.1111/trf.16323 -
NLM
Wendel S, Wendel RF, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano MT, Machado RRG, Araujo DB, Soares CP, Durigon EL. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections [Internet]. Transfusion. 2021 ;14 .[citado 2026 mar. 31 ] Available from: https://doi.org/10.1111/trf.16323 -
Vancouver
Wendel S, Wendel RF, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano MT, Machado RRG, Araujo DB, Soares CP, Durigon EL. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections [Internet]. Transfusion. 2021 ;14 .[citado 2026 mar. 31 ] Available from: https://doi.org/10.1111/trf.16323 - A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections
- Anti‐A and SARS‐CoV‐2: an intriguing association
- Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be?
- Development and validation of an enzyme-linked immunoassay kit for diagnosis and surveillance of COVID-19
- Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice
- Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
- Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program
- SARS-CoV-2 rapid antigen test based on a new anti-nucleocapsid protein monoclonal antibody: development and real-time validation
- Heterogeneous development of children with congenital Zika Syndrome-associated microcephaly
- Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
